Alex Wyatt
Alex Wyatt, MD, DPhil
Alex Wyatt holds the President’s Excellence Chair in Precision Oncology and is an Associate Professor at the University of British Columbia, Canada. He serves as Scientific Director of the Clinical Cancer Genomics Program at BC Cancer, where he is also a Senior Scientist in Basic and Translational Research. In addition, he is a Senior Research Scientist at the Vancouver Prostate Centre. Wyatt co-chairs correlative sciences and tumor biobanking for the Canadian Cancer Trials Group (CCTG), contributing to the design and execution of phase 2–3 clinical trial protocols across Canada.
Disclosures: Advisory boards and/or honoraria from Astellas Pharma, AstraZeneca, Bayer, Janssen, Merck, and Pfizer. Received research funding from ESSA Pharma (institutional), Promontory Therapeutics (institutional), and Tyra Biosciences (institutional).
View content featuring Wyatt:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.